(Reuters) -The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 ...

(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA ...

Dr. Vinay Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA’s Center for Biologics Evaluation and ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research ...

and Pfizer (PFE), who each had COVID-19 vaccines of their own, Novavax’s Nuvaxovid never became a household name. The company could not successfully navigate the complex regulatory and market ...

He succeeds Peter Marks, who oversaw the approval of COVID-19 vaccines and was pushed out ... treatment for Duchenne muscular dystrophy. Pfizer (NYSE:PFE) shares fell 3%. Smaller gene therapy ...

There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are ...

Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...

The Slovak government halted purchases of COVID-19 vaccines on Wednesday pending a review of their safety by the Slovak Academy of Sciences, Prime Minister Robert Fico said. Fico, a populist who has ...